Literature DB >> 3527624

Osteopenia in mice with genetic diabetes.

R Lorentzon, U Alehagen, L Boquist.   

Abstract

Bone mass and growth were studied in mice with genetic diabetes (db/db) characterized by obesity, hyperinsulinemia and hyperglycemia, in their lean litter mates (db/+) and in non-diabetic mice of the same strain (+/+). No significant difference was observed between db/+ and +/+ mice. The length, bone mass, bone mineral mass, bone mineral density and content of moisture of the tibia of the db/db mice were significantly decreased compared with the db/+ and +/+ mice. Microradiographs of the distal femur diaphysis of the db/db mice showed a significant reduction of the spongious bone area and of the number and thickness of bone trabeculae with a normal mineralization. The amount of osteoid was significantly increased in the db/db mice. The area of cortical bone of the tibia epiphysis of the db/db mice was significantly decreased compared with the db/+ and +/+ mice. The data suggest the occurrence of osteopenia due to decreased mineralization in mice with genetic diabetes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527624     DOI: 10.1016/s0168-8227(86)80017-1

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model.

Authors:  Elizabeth Rendina-Ruedy; Brenda J Smith
Journal:  Bonekey Rep       Date:  2016-10-26

2.  Does obesity affect fracture healing in children?

Authors:  Rushyuan J Lee; Nigel N Hsu; Colleen M Lenz; Arabella I Leet
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

3.  Effects of increased hypothalamic leptin gene expression on ovariectomy-induced bone loss in rats.

Authors:  M A Jackson; U T Iwaniec; R T Turner; T J Wronski; S P Kalra
Journal:  Peptides       Date:  2011-05-27       Impact factor: 3.750

Review 4.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 5.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

Review 6.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.

Authors:  Katherine J Motyl; Laura R McCabe
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

Review 8.  Fat targets for skeletal health.

Authors:  Masanobu Kawai; Maureen J Devlin; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2009-05-26       Impact factor: 20.543

9.  Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice.

Authors:  Hee Yeon Won; Jin-Ah Lee; Zong Sik Park; Jin Sook Song; Hee Yun Kim; Su-Min Jang; Sung-Eun Yoo; Youmi Rhee; Eun Sook Hwang; Myung Ae Bae
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  Are volumetric bone mineral density and bone micro-architecture associated with leptin and soluble leptin receptor levels in adolescent idiopathic scoliosis?--A case-control study.

Authors:  Elisa M S Tam; Fiona W P Yu; Vivian W Y Hung; Zhen Liu; King Lok Liu; Bobby K W Ng; Simon K M Lee; Yong Qiu; Jack C Y Cheng; Tsz-Ping Lam
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.